SIGMAR1 and Parkinson disease: Overall, Sigmar1 activation has shown protective effects in different neurodegenerative diseases (AD, HD, PD) through the involvement of different cellular pathway modulation, including mitochondrial function regulation, autophagy, calcium homeostasis regulation, and chaperone function.